Silica-based controlled-release drug delivery technology
| Date | Round | Amount |
|---|---|---|
| Jan 2024 | Funding round Turku drug-delivery company DelSiTech raised EUR 10M from DRW Venture Capital and Tolmar to advance its silica-based platform into clinical development. | $10.8M |
| Feb 2023 | Grant Turku drug-delivery company DelSiTech received a grant from the Bill & Melinda Gates Foundation for long-acting HIV-vaccine formulations. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.